Preparation and Characterization of Cyclodextrin Inclusion Complexes for Improving Solubility and Dissolution of Nimesulide

Author : Ajay Semalty, Yuveraj Singh Tanwar

Nimesulide (4\'-nitro-2\'-phenoxy methane sulfonanilide) is a selective cyclooxygenase-2 inhibitor and one of the potent non steroidal anti-inflammatory drugs (NSAIDs). It is practically insoluble in water and hence has a low bioavailability. To improve solubility and dissolution of nimesulide, its β-cyclodextrin complex were prepared.Nimesulide was complexed with β-cyclodextrin in 1:1, 1:2 and 1:3 molar ratios using solvent evaporation method with the addition of freeze drying. The prepared inclusion complexes were evaluated for solubility, scanning electron microscopy (SEM), differential scanning calorimetry (DSC), X ray powder diffraction (XRPD) and in vitro dissolution study. All the complexes showed about up to 12 fold increase in solubility. The complex prepared in 1:3 ratios showed the greatest improvement in solubility (from 9.67 to 108.60 μg/ml). In SEM, the complexes showed irregular disc shaped non-porous surface. XRPD data indicated that maximum amorphization was induced in the complex prepared with 1:2 ratio. The DSC data confirmed the formation of inclusion complex. The dissolution of the drug in the complexes was also found to be improved. Complex prepared by solvent evaporation method in 1:2 molar ratio showed a marked improvement in dissolution profile (complete release in just 30 minutes) than that of pure drug which showed just 60.02 % drug release at the end of 3 hour. It was concluded that the β-cyclodextrin complex made in 1:2 molar ratio showed good solubility and the dissolution profile as compared to the complex made in 1:1 and 1:3 molar ratio. It was concluded that the complex prepared by solvent evaporation method with 1:2 molar ratio showed the best performance with respect to great improvement in solubility, the best amorphization and the best in vitro dissolution profile as compared to other complexes.

Full Text Attachment

Creative Commons License World Journal of Pharmaceutical Science is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at Permissions beyond the scope of this license may be available at